Oruka Therapeutics, Inc. ORKA Available-for-Sale Debt Securities - Unrealized Loss Position
Available-for-Sale Debt Securities - Unrealized Loss Position at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s available-for-sale debt securities - unrealized loss position.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s available-for-sale debt securities - unrealized loss position?
- Oruka Therapeutics, Inc. (ORKA) reported available-for-sale debt securities - unrealized loss position of $553K in Q1 2026.
- How has Oruka Therapeutics, Inc.'s available-for-sale debt securities - unrealized loss position changed year-over-year?
- Oruka Therapeutics, Inc.'s available-for-sale debt securities - unrealized loss position increased by 1102.2% year-over-year, from $46K to $553K.
- What does available-for-sale debt securities - unrealized loss position mean?
- This represents the total value of available-for-sale debt securities currently held at a fair market value below their amortized cost basis. It provides a comprehensive view of the unrealized loss exposure within the company's debt investment portfolio.